Results 291 to 300 of about 157,757 (356)

Genetically Modified MSCs for Targeted Regeneration: Balancing Efficacy, Biosafety, and GMP Standardization. [PDF]

open access: yesCells
Kitaeva KV   +6 more
europepmc   +1 more source

High-specificity local and global c-di-GMP signaling

Trends in Microbiology, 2021
The striking multiplicity, signal input diversity, and output specificity of c-di-GMP signaling proteins in many bacteria has brought second messenger signaling back onto the agenda of contemporary microbiology.
Regine Hengge
exaly   +2 more sources

Biofilm control by interfering with c-di-GMP metabolism and signaling

Biotechnology Advances, 2022
Biofilm formation and biofilm-induced biodeterioration of surfaces have deeply affected the life of our community. Cyclic dimeric guanosine monophosphate (c-di-GMP) is a small nucleic acid signal molecule in bacteria, which functions as a second ...
Liang Yang, Xiaobo Liu, Bin Cao
exaly   +2 more sources

Translating mesenchymal stem cell and their exosome research into GMP compliant advanced therapy products: Promises, problems and prospects

Medicinal research reviews (Print), 2023
Mesenchymal stem cells (MSCs) are one of the few stem cell types used in clinical practice as therapeutic agents for immunomodulation and ischemic tissue repair, due to their unique paracrine capacity, multiple differentiation potential, active ...
C. Ma   +7 more
semanticscholar   +1 more source

Human GMP synthetase

International Journal of Biochemistry, 1984
The specific activity of GMP synthetase was measured in several human tissues and found to be highest in cultured skin fibroblasts, followed by bone marrow, leukocytes, erythrocytes, placenta, and liver. The enzyme from fibroblasts was purified approximately 50-fold by ammonium sulfate fractionation and gel filtration.
T, Page, B, Bakay, W L, Nyhan
openaire   +2 more sources

Home - About - Disclaimer - Privacy